Maike Zimmermann - Concepedia

Author

Maike Zimmermann

University of California, Davis ORCID

Also Known As

Maike Zimmermann

Publications

636

Citations

H-Index

Concepts

All Affiliations

University of California, Davis Lawrence Livermore National Laboratory VA Northern California Health Care System University of California Davis Medical Center Accelerated Medical Diagnostics (United States)

About

Maike Zimmermann is an author at University of California, Davis specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	390
2	Cell Biology	5	5	330
3	Cellular Physiology	2	2	70
4	Natural Sciences	1	1	51
5	Biochemistry	1	1	51

Maike Zimmermann

Publications

581

Citations

H-Index

Page 1

	Year	Citations
mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells Jiaxi Zhou, Pei Su, Lu Wang, Proceedings of the National Academy of Sciences Long-term Self-renewalAdult Stem CellMtor Impairs PluripotencyEndoderm ActivitiesSuppresses Mesoderm	2009	207
DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine Alessia Stornetta, Maike Zimmermann, George D. Cimino, Chemical Research in Toxicology Chemoprevention StrategyPathologyNucleic Acid BiomarkersBiomarker-driven Drug SelectionMedicinal Chemistry	2016	60
Elevated Cyclin G2 Expression Intersects with DNA Damage Checkpoint Signaling and Is Required for a Potent G2/M Checkpoint Arrest Response to Doxorubicin Maike Zimmermann, Aruni S. Arachchige-Don, Michaela S. Donaldson, Journal of Biological Chemistry	2012	59
Targeting of Protein Phosphatases PP2A and PP2B to the C-Terminus of the L-Type Calcium Channel Ca<sub>v</sub>1.2 Hui Xu, Kenneth S. Ginsburg, Duane D. Hall, Biochemistry Cardiac MuscleSynaptic TransmissionSynaptic SignalingCellular PhysiologyTrimeric G	2010	51
Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival Maike Zimmermann, Aruni P. S. Arachchige-Don, Michaela S. Donaldson, Cell Cycle Breast OncologyEstrogen ReceptorCell CycleCancer BiologyTumor Biology	2016	38
COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin Fuli Wang, Hongyong Zhang, Ai-Hong Ma, Molecular Cancer Therapeutics	2017	35
Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice Maike Zimmermann, Si-Si Wang, Hongyong Zhang, Molecular Cancer Therapeutics	2016	25
A Simple Three-Dimensional In Vitro Culture Mimicking the In Vivo-Like Cell Behavior of Bladder Patient-Derived Xenograft Models Robson Amaral, Maike Zimmermann, Ai-Hong Ma, Cancers	2020	23
Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy Maike Zimmermann, Tao Li, Thomas J. Semrad, Molecular Cancer Therapeutics	2020	22
Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis Angela Manegold Svendsen, Sofia Boeg Winge, Maike Zimmermann, Biochemical Journal Cell ProliferationInsulin ReceptorCell GrowthCellular PhysiologyInsulin Signaling	2013	19

Page 1